Skip to main content
. 2012 Oct 18;107(11):1820–1825. doi: 10.1038/bjc.2012.470

Figure 3.

Figure 3

Subgroup analyses by VeriStrat classification. (A) OS for adenocarcinoma patients, (B) PFS for adenocarcinoma patients, (C) OS for ever-smokers and (D) PFS for ever-smokers.